- Home
- NVT vs BAX Comparison
NVT vs BAX Comparison
Compare NVT & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVT
- BAX
- Stock Information
- Founded
- NVT 1903
- BAX 1931
- Country
- NVT United Kingdom
- BAX United States
- Employees
- NVT N/A
- BAX N/A
- Industry
- NVT Industrial Machinery/Components
- BAX Medical/Dental Instruments
- Sector
- NVT Industrials
- BAX Health Care
- Exchange
- NVT Nasdaq
- BAX Nasdaq
- Market Cap
- NVT 11.5B
- BAX 11.6B
- IPO Year
- NVT N/A
- BAX N/A
- Fundamental
- Price
- NVT $88.00
- BAX $24.18
- Analyst Decision
- NVT Strong Buy
- BAX Hold
- Analyst Count
- NVT 11
- BAX 9
- Target Price
- NVT $79.91
- BAX $32.00
- AVG Volume (30 Days)
- NVT 2.3M
- BAX 10.5M
- Earning Date
- NVT 08-01-2025
- BAX 07-31-2025
- Dividend Yield
- NVT 0.91%
- BAX 2.81%
- EPS Growth
- NVT 2.58
- BAX N/A
- EPS
- NVT 3.51
- BAX N/A
- Revenue
- NVT $3,306,600,000.00
- BAX $10,887,000,000.00
- Revenue This Year
- NVT $20.02
- BAX $8.05
- Revenue Next Year
- NVT $9.53
- BAX $4.19
- P/E Ratio
- NVT $57.43
- BAX N/A
- Revenue Growth
- NVT 14.92
- BAX 3.60
- 52 Week Low
- NVT $41.71
- BAX $21.33
- 52 Week High
- NVT $92.75
- BAX $40.49
- Technical
- Relative Strength Index (RSI)
- NVT 63.59
- BAX 39.61
- Support Level
- NVT $89.00
- BAX $23.72
- Resistance Level
- NVT $92.75
- BAX $23.86
- Average True Range (ATR)
- NVT 2.61
- BAX 0.90
- MACD
- NVT 0.01
- BAX 0.14
- Stochastic Oscillator
- NVT 67.73
- BAX 37.09
About NVT nVent Electric plc
nVent is a leading global provider of electrical connection and protection solutions that touches a broad range of end markets including infrastructure, industrial, commercial, and residential. NVent designs, manufacturers, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. North America accounts for the majority of sales.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.